Pediatrix Medical Group (MD) Stock Statistics & Valuation Metrics
Total Valuation
Pediatrix Medical Group has a market cap or net worth of MXN 43.78B. The enterprise value is MXN 2.24B.
- Market Cap
- MXN 43.78B
- Enterprise Value
- MXN 2.24B
Share Statistics
Pediatrix Medical Group has 78,124,720 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 78,124,720
- Owned by Insiders
- 1.62%
- Owned by Institutions
- 74.33%
Financial Efficiency
Pediatrix Medical Group’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 9.67%.
- Return on Equity (ROE)
- 0.19
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 9.67%
- Return on Capital Employed (ROCE)
- 0.13
- Revenue Per Employee
- 447.16K
- Profits Per Employee
- 38.64K
- Employee Count
- 4,280
- Asset Turnover
- 0.85
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Pediatrix Medical Group is 15.95. Pediatrix Medical Group’s PEG ratio is -15.07.
- PE Ratio
- 15.95
- PS Ratio
- 1.19
- PB Ratio
- 2.71
- Price to FCF
- 11.10
- Price to Operating Cash Flow
- 10.14
- PEG Ratio
- -15.07
Income Statement
In the last 12 months, Pediatrix Medical Group had revenue of 1.91B and earned 165.39M in profits. Earnings per share was 1.94.
- Revenue
- 1.91B
- Gross Profit
- 471.88M
- Operating Income
- 231.09M
- Pretax Income
- 216.43M
- Net Income
- 165.39M
- EBITDA
- 274.22M
- Earnings Per Share (EPS)
- 1.94
Cash Flow
In the last 12 months, operating cash flow was 227.23M and capital expenditures -17.29M, giving a free cash flow of 209.94M billion.
- Operating Cash Flow
- 227.23M
- Free Cash Flow
- 209.94M
- Free Cash Flow per Share
- 2.72
Dividends & Yields
Pediatrix Medical Group pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 9.01%
- Earnings Yield
- 6.51%
Stock Price Statistics
- Beta
- 0.36
- 52-Week Price Change
- 67.61%
- 50-Day Moving Average
- 463.62
- 200-Day Moving Average
- 404.80
- Relative Strength Index (RSI)
- 82.72
- Average Volume (3m)
- 24
Important Dates
Pediatrix Medical Group upcoming earnings date is Feb 18, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Feb 18, 2027
- Ex-Dividend Date
- ―
Financial Position
Pediatrix Medical Group as a current ratio of 1.66, with Debt / Equity ratio of 76.26%
- Current Ratio
- 1.66
- Quick Ratio
- 1.66
- Debt to Market Cap
- 0.35
- Net Debt to EBITDA
- 1.04
- Interest Coverage Ratio
- 6.43
Taxes
In the past 12 months, Pediatrix Medical Group has paid 51.04M in taxes.
- Income Tax
- 51.04M
- Effective Tax Rate
- 0.24
Enterprise Valuation
Pediatrix Medical Group EV to EBITDA ratio is 10.52, with an EV/FCF ratio of 12.53.
- EV to Sales
- 1.34
- EV to EBITDA
- 10.52
- EV to Free Cash Flow
- 12.53
- EV to Operating Cash Flow
- 11.57
Balance Sheet
Pediatrix Medical Group has MXN 425.84M in cash and marketable securities with MXN 612.00M in debt, giving a net cash position of -MXN 186.16M billion.
- Cash & Marketable Securities
- MXN 425.84M
- Total Debt
- MXN 612.00M
- Net Cash
- -MXN 186.16M
- Net Cash Per Share
- -MXN 2.38
- Tangible Book Value Per Share
- -MXN 5.59
Margins
Gross margin is 25.83%, with operating margin of 11.40%, and net profit margin of 7.66%.
- Gross Margin
- 25.83%
- Operating Margin
- 11.40%
- Pretax Margin
- 10.38%
- Net Profit Margin
- 7.66%
- EBITDA Margin
- 12.76%
- EBIT Margin
- 11.55%
Analyst Forecast
The average price target for Pediatrix Medical Group is MXN 511.36, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- MXN 511.36
- Price Target Upside
- 2.72% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 6
- Revenue Growth Forecast
- -8.59%
- EPS Growth Forecast
- -10.55%
Scores
- Smart Score
- 7
- AI Score
- ―
